Takeda has established two new entities in Singapore: Takeda Clinical Research Singapore (TCRS) and Takeda Pharmaceuticals Asia (TPAsia). TCRS will serve as the company's center of clinical development in the Asia-Oceania region, in close coordination with the company’s clinical development activities in Japan, Europe and the U.S. Through this centre, Takeda seeks to expand access to patients on a global scale, to achieve the earliest possible application, approval and launch of its new product in its target markets worldwide.

At the same time, TCRS will also work closely with Takeda Pharmaceuticals Asia, which will supervise the overall business activities of Takeda's sales and marketing subsidiaries in five Asian countries: Taiwan, Thailand, the Philippines, Indonesia and China.